Robert C. Pozen

Robert C. Pozen is currently a Senior Lecturer at the MIT Sloan School of Management and a nonresident senior fellow at the Brookings Institution. In 2012, he won acclaim for a popular book entitled “Extreme Productivity: Boost Your Results, Reduce Your Hours”. In the Spring of 2021, he co-authored a new book on productivity entitled, “Remote Inc.: How to Thrive at Work…Wherever You Are.”

In 2004, Pozen became the executive chairman of MFS Investment Management, which now manages over $400 billion for mutual funds and pension plans. Between 2004 and 2011, MFS’s assets under management nearly tripled from a base of $130 billion. Prior to joining MFS, he was vice chairman of Fidelity Investments and president of Fidelity Management & Research Company. During his five years as president, from 1997 to 2001, Fidelity’s assets increased from $500 billion to almost $1 trillion.

Beyond his executive roles, Bob has held various governmental positions in the United States. In late 2001 and 2002, Bob served on President Bush’s Commission to Strengthen Social Security, where he developed a progressive plan to make the system solvent. In 2003, Bob served as Secretary of Economic Affairs for Massachusetts Governor Mitt Romney. In 2007, he served as chairman of the SEC’s Committee to Improve Financial Reporting.

Similarly, Bob has been active in the international finance area. He has long served as an independent director of AMC, a part of the World Bank Group, which co-invests private monies with those of the International Finance Corporation. More recently, he has become a trustee of the IFRS Foundation, which is the parent of both the International Accounting Board and the International Sustainability Standards Board.  After graduating from Yale Law School, he obtained a doctorate there for a book entitled “Legal Choices for State Enterprises in Africa.”

Bob is currently chair of the Leadership Council of the Tax Policy Center, and chair of the Advisory Board of Agility (an outsourced CIO). He is also a member of the Council on Foreign Relations and a fellow of the American Academy of Arts and Sciences. He currently serves on the board of Brixton Biosciences, a private biotech, and ReBoot Rx, a nonprofit dedicated to repurposing generic drugs. He was previously an independent director of Medtronic, Nielsen, and BCE (parent of Bell Canada).

Bob holds a BA, summa cum laude, from Harvard, and a JD from Yale Law School, where he was on the editorial board of the Yale Law Journal. He frequently writes articles for MarketWatch, the Wall Street Journal, and the Harvard Business Review. He has published a book on the 2008 financial crisis, “Too Big To Save? How to Fix the US Financial System,” and a guide for investors entitled “The Fund Industry: How Your Money is Managed.”